Breaking News, Financial News

Financial Report: GlaxoSmithKline

Bribery allegations impact sales in China

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

GlaxoSmithKline   3Q Revenues: £6.5 billion (flat) 3Q Earnings: £1.9 billion (+12%) YTD Revenues: £19.6 billion (flat) YTD Earnings: £5.4 billion (flat) Comments: Pharmaceuticals and Vaccines sales were flat at £5.2 billion in the quarter. In the U.S. sales were up 2% to £1.9 billion, with Pharmaceuticals down 3% due to a decline in Respiratory sales, and Vaccines up 24% due to a 69% increase in Infanrix/Pediarix, which continued to benefit from a competitor supply shortage, and a 29% increa...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters